{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:11:50Z","timestamp":1709889110808},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<p><strong>ABSTRACT<\/strong><br \/><strong>BACKGROUND.<\/strong> The year 2020 in the extent of HCV infection was set for the first milestones on the road\u00a0to the eradication of HCV infection in 2030. In addition, in 2020 there was a global public health crisis \u2013 the\u00a0COVID-19 pandemic. The aim of this paper was to assess the epidemiological situation of HCV infection based\u00a0on epidemiological surveillance data in Poland in 2020.<br \/><strong>MATERIAL AND METHODS.<\/strong> Analysis of: 1) individual data from surveillance in 2020 conducted by\u00a0EpiBaza system; 2) diagnosis rate from bulletins \u201cInfectious diseases and poisonings in Poland\u201d for the years\u00a02014-2020; and 3) data about deaths due to hepatitis C from the Demographic Surveys and Labour Market\u00a0Department of Statistics Poland.<br \/><strong>RESULTS.<\/strong> In 2020, there was a significant decrease in the number of reported cases and thus in the diagnosis\u00a0rate of HCV infection in Poland \u2013 955 HCV infections were reported (2.49\/100,000 \u2013 in comparison with 2019,\u00a03.5 times less). The decrease occurred in all voivodeships (ranging from 0.50 to 6.37\/100,000), we observe more\u00a0districts in which HCV infections were not detected (in 2020 \u2013 35.3%; in 2019 \u2013 16.8%). The diagnosis rate\u00a0of HCV infection in women and men was at a similar level. However, large disproportions are visible if age\u00a0groups are considered in addition to gender. For years, we have observed a variation of the diagnosis rate of\u00a0HCV infection depending on the environment of residence \u2013 also in 2020, higher values were reported overall\u00a0in residents of urban than in rural areas (2.90 vs. 1.88\/100,000). In 2.9% of newly diagnosed HCV infections,\u00a0at the same time cirrhosis was already present, 0.4% had liver failure, and 0.1% had hepatocellular carcinoma.\u00a0Among exposures of HCV infection, those related to nosocomial transmission still dominate (59%), also in acute\u00a0hepatitis C (60%). One-third of reported infections were diagnosed in primary health care, and one in four were\u00a0diagnosed during hospitalization.<br \/><strong>CONCLUSIONS.<\/strong> The data presented in this paper show that the COVID-19 pandemic deepened the inequalities\u00a0observed for years in HCV areas. Establishing a diverse system of testing and linking to care in Poland, reaching\u00a0those in the greatest risk of ongoing transmission of HCV infection, and providing methodologically correct\u00a0studies to assess progress in the eradication of HCV infection is becoming increasingly urgent to achieve the\u00a0planned 2030 WHO targets.<\/p>\n<p><strong>STRESZCZENIE<\/strong><br \/><strong>WPROWADZENIE.<\/strong> Rok 2020 w obszarze zaka\u017ce\u0144 HCV by\u0142 rokiem, w kt\u00f3rym powinny zosta\u0107 osi\u0105gni\u0119te\u00a0pierwsze kamienie milowe na drodze do eliminacji zaka\u017ce\u0144 w 2030 r. Dodatkowo w 2020 r. nast\u0105pi\u0142 og\u00f3lno\u015bwiatowy\u00a0kryzys zdrowia publicznego \u2013 pandemia COVID-19. Celem publikacji by\u0142a ocena sytuacji epidemiologicznej\u00a0zaka\u017ce\u0144 HCV bazuj\u0105c na danych nadzoru epidemiologicznego w Polsce w 2020 r.<br \/><strong>MATERIA\u0141 I METODA.<\/strong> Przeanalizowano: 1) dane jednostkowe przypadk\u00f3w zg\u0142oszonych do nadzoru epidemiologicznego,\u00a0prowadzonego w 2020 r. za pomoc\u0105 systemu EpiBaza; 2) wska\u017aniki rozpozna\u0144 z biuletyn\u00f3w\u00a0\u201eChoroby zaka\u017ane i zatrucia w Polsce\u201d za lata 2014-2020 oraz 3) dane dotycz\u0105ce zgon\u00f3w z powodu wzw C z\u00a0Departamentu Bada\u0144 Demograficznych i Rynku Pracy, G\u0142\u00f3wnego Urz\u0119du Statystycznego.<br \/><strong>WYNIKI.<\/strong> W 2020 r. odnotowano znacz\u0105cy spadek liczby zg\u0142oszonych przypadk\u00f3w, a tym samym wska\u017anika\u00a0rozpozna\u0144 zaka\u017ce\u0144 HCV w Polsce \u2013 zaraportowano 955 zaka\u017ce\u0144 HCV (2,49\/100 tys. \u2013 w por\u00f3wnaniu do 2019 r.\u00a0odnotowano 3,5 razy mniej). Spadek nast\u0105pi\u0142 we wszystkich wojew\u00f3dztwach (wska\u017aniki w wojew\u00f3dztwach\u00a0wynosi\u0142y od 0,50 do 6,37\/100 tys.), zaobserwowano wi\u0119cej powiat\u00f3w i miast na prawach powiat\u00f3w, w kt\u00f3rych\u00a0nie wykryto zaka\u017ce\u0144 HCV (w 2020 r. \u2013 35,3%; w 2019 r. \u2013 16,8%). Wsp\u00f3\u0142czynnik rozpozna\u0144 zaka\u017ce\u0144 HCV kobiet\u00a0i m\u0119\u017cczyzn kszta\u0142towa\u0142 si\u0119 na podobnym poziomie. Jednak\u017ce zauwa\u017calne s\u0105 du\u017ce dysproporcje, je\u015bli obok\u00a0p\u0142ci uwzgl\u0119dni si\u0119 grupy wieku. Od lat obserwujemy zr\u00f3\u017cnicowanie warto\u015bci wska\u017anika rozpozna\u0144 zaka\u017ce\u0144\u00a0HCV w zale\u017cno\u015bci od \u015brodowiska zamieszkania \u2013 r\u00f3wnie\u017c w 2020 r. wy\u017csze warto\u015bci odnotowano og\u00f3\u0142em u\u00a0mieszka\u0144c\u00f3w teren\u00f3w miejskich ni\u017c wiejskich (2,90 vs. 1,88\/100 tys.). U 2,9% nowo rozpoznanych zaka\u017ce\u0144\u00a0HCV jednoczasowo wyst\u0119powa\u0142a ju\u017c marsko\u015b\u0107 w\u0105troby, u 0,4% niewydolno\u015b\u0107 w\u0105troby, a u 0,1% rak w\u0105trobowokom\u00f3rkowy.\u00a0W\u015br\u00f3d nara\u017ce\u0144 zaka\u017cenia HCV wci\u0105\u017c dominuj\u0105 te zwi\u0105zane z pobytem w plac\u00f3wce ochrony\u00a0zdrowia (59%), r\u00f3wnie\u017c w\u015br\u00f3d ostrych wzw C (60%). Jedna trzecia zg\u0142oszonych zaka\u017ce\u0144 zosta\u0142a rozpoznana w\u00a0podstawowej opiece zdrowotnej, co czwarte rozpoznanie nast\u0105pi\u0142o podczas hospitalizacji.<br \/><strong>WNIOSKI.<\/strong> Przedstawione dane wskazuj\u0105, \u017ce pandemia COVID-19 pog\u0142\u0119bi\u0142a obserwowane od lat nier\u00f3wno\u015bci\u00a0w temacie HCV. Stworzenie w Polsce zr\u00f3\u017cnicowanego systemu testowania i \u0142\u0105czenia z dalsz\u0105 opiek\u0105 os\u00f3b zaka\u017conych,\u00a0docieraj\u0105cego do os\u00f3b najbardziej nara\u017conych na bie\u017c\u0105c\u0105 transmisj\u0119 zaka\u017cenia HCV oraz zapewnienie\u00a0poprawnych metodologicznie bada\u0144 oceniaj\u0105cych post\u0119py w eradykacji zaka\u017ce\u0144 HCV jest coraz bardziej pal\u0105ce,\u00a0by osi\u0105gn\u0105\u0107 zaplanowane na 2030 r. cele WHO.<\/p><\/jats:p>","DOI":"10.32394\/pe.76.23","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:29:17Z","timestamp":1666704557000},"page":"233-242","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C in Poland in 2020"],"prefix":"10.32394","volume":"76","author":[{"given":"K","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rosi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2022,10,25]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["Wirusowe zapalenie w\u0105troby typu C (wzw C) w Polsce w 2020 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181066-101627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181066-101627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:44:02Z","timestamp":1709887442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Hepatitis-C-in-Poland-in-2020,181066,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"alternative-id":["181066"],"URL":"https:\/\/doi.org\/10.32394\/pe.76.23","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}